CL2014001823A1 - Procedimiento de preparacion estereoselectiva de un compuesto derivado de 9-hidroxi-5-oxo-1,4-diaza-espiro [5.5] undecano; compuestos intermediarios; uso en el tratamiento de enfermedades tumorales, enfermedades del pulmon y de las vias respiratorias. - Google Patents

Procedimiento de preparacion estereoselectiva de un compuesto derivado de 9-hidroxi-5-oxo-1,4-diaza-espiro [5.5] undecano; compuestos intermediarios; uso en el tratamiento de enfermedades tumorales, enfermedades del pulmon y de las vias respiratorias.

Info

Publication number
CL2014001823A1
CL2014001823A1 CL2014001823A CL2014001823A CL2014001823A1 CL 2014001823 A1 CL2014001823 A1 CL 2014001823A1 CL 2014001823 A CL2014001823 A CL 2014001823A CL 2014001823 A CL2014001823 A CL 2014001823A CL 2014001823 A1 CL2014001823 A1 CL 2014001823A1
Authority
CL
Chile
Prior art keywords
diseases
undecano
diaza
spiro
oxo
Prior art date
Application number
CL2014001823A
Other languages
English (en)
Spanish (es)
Inventor
Juergen Schnaubelt
Wenjun Tang
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of CL2014001823A1 publication Critical patent/CL2014001823A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/113Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
CL2014001823A 2012-02-09 2014-07-09 Procedimiento de preparacion estereoselectiva de un compuesto derivado de 9-hidroxi-5-oxo-1,4-diaza-espiro [5.5] undecano; compuestos intermediarios; uso en el tratamiento de enfermedades tumorales, enfermedades del pulmon y de las vias respiratorias. CL2014001823A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12154688 2012-02-09

Publications (1)

Publication Number Publication Date
CL2014001823A1 true CL2014001823A1 (es) 2015-03-06

Family

ID=47678813

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2014001823A CL2014001823A1 (es) 2012-02-09 2014-07-09 Procedimiento de preparacion estereoselectiva de un compuesto derivado de 9-hidroxi-5-oxo-1,4-diaza-espiro [5.5] undecano; compuestos intermediarios; uso en el tratamiento de enfermedades tumorales, enfermedades del pulmon y de las vias respiratorias.

Country Status (14)

Country Link
US (1) US8629146B2 (enExample)
EP (1) EP2812317B1 (enExample)
JP (1) JP6105631B2 (enExample)
KR (1) KR20140128318A (enExample)
CN (1) CN104080775A (enExample)
AU (1) AU2013218119A1 (enExample)
BR (1) BR112014019196A8 (enExample)
CA (1) CA2862520A1 (enExample)
CL (1) CL2014001823A1 (enExample)
EA (1) EA201400882A1 (enExample)
IL (1) IL233370A (enExample)
MX (1) MX2014009033A (enExample)
PH (1) PH12014501760A1 (enExample)
WO (1) WO2013117568A1 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2289881A1 (de) * 2009-08-06 2011-03-02 Boehringer Ingelheim International GmbH Verfahren zur stereoselektiven Synthese bicyclischer Heterocyclen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4575507A (en) * 1985-05-29 1986-03-11 Pfizer Inc. Spiro-imidazolidines as aldose reductase inhibitors and their pharmaceutical use
ATE557008T1 (de) 2002-03-30 2012-05-15 Boehringer Ingelheim Pharma 4- ( n-phenylamino ) -chinazoline/chinoline als tyrosinkinaseinhibitoren
US6924285B2 (en) 2002-03-30 2005-08-02 Boehringer Ingelheim Pharma Gmbh & Co. Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
CA2631813A1 (en) 2005-12-12 2007-06-21 Boehringer Ingelheim International Gmbh Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for the production thereof
PT2245026E (pt) 2008-02-07 2012-10-15 Boehringer Ingelheim Int Heterociclos espirocíclicos, produtos farmacêuticos contendo estes compostos, sua utilização e processo para a sua preparação
EP2289881A1 (de) 2009-08-06 2011-03-02 Boehringer Ingelheim International GmbH Verfahren zur stereoselektiven Synthese bicyclischer Heterocyclen
PE20141012A1 (es) * 2011-02-01 2014-09-10 Boehringer Ingelheim Int Dimaleato de 9-[4-(3-cloro-2-fluoro-fenilamino)-7-metoxi-quinazolin-6-iloxi]-1,4-diaza-espiro[5.5]undecan-5-ona, su uso como medicamento y su preparacion

Also Published As

Publication number Publication date
EP2812317B1 (de) 2016-02-03
BR112014019196A8 (pt) 2017-07-11
PH12014501760B1 (en) 2014-11-10
US8629146B2 (en) 2014-01-14
BR112014019196A2 (enExample) 2017-06-20
WO2013117568A1 (de) 2013-08-15
EP2812317A1 (de) 2014-12-17
CN104080775A (zh) 2014-10-01
CA2862520A1 (en) 2013-08-15
US20130211081A1 (en) 2013-08-15
EA201400882A1 (ru) 2015-01-30
KR20140128318A (ko) 2014-11-05
JP6105631B2 (ja) 2017-03-29
AU2013218119A1 (en) 2014-07-17
IL233370A (en) 2015-04-30
IL233370A0 (en) 2014-08-31
PH12014501760A1 (en) 2014-11-10
MX2014009033A (es) 2014-10-17
JP2015506966A (ja) 2015-03-05

Similar Documents

Publication Publication Date Title
CY1122292T1 (el) Ενωσεις και μεθοδοι για αντιϊικη αγωγη
HUE036000T2 (hu) Claudin 18.2 ellen irányuló antitesteket magában foglaló kombinációs terápia rák kezelésére
LT2726511T (lt) Kompozicijos, panaudojimai ir būdai, skirti metabolinių sutrikimų ir ligų gydymui
WO2011140517A9 (en) Methods for treating diseases of the lung
HUE053113T2 (hu) Bardoxolon-metil 2,2-difluorpropionamid-származéka, annak gyógyszerkészítményei és polimorfjai bizonyos betegségek kezelésében történõ alkalmazásra
IL230458A0 (en) Compounds for the treatment and prevention of respiratory syncytial viral disease
AP2014007533A0 (en) Substituted benzylindazoles for use as BUB1 kinaseinhibitors in the treatment of hyperproliferative diseases
LT3292875T (lt) Kompozicijos ir būdai, skirti ligų gydymui
IL225262A0 (en) Methods and compositions for treating lung cancer
ZA201403549B (en) Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or anti-adm non-ig scaffold for use in therapy of an acute disease or acute condition of a patient for stabilizing the circulation
PL2771329T3 (pl) Nowe związki di-podstawione 3,4-diamino-3-cyklobuteno- 1,2-dionu do zastosowania w leczeniu patologii, w których pośredniczą chemokiny
LT3890767T (lt) Inhaliuojamos kompozicijos, skirtos naudoti plaučių ligų gydymui
PL2726470T3 (pl) Pochodne 1,2,4-tiadiazol-5-ilo piperazyny przydatne w leczeniu chorób neurodegeneracyjnych
LTPA2020511I1 (lt) Ciklezonidas, skirtas arklių kvėpavimo takų ligų gydymui
PL3260865T3 (pl) Sposób obróbki krwi, produktów krwiopochodnych i narządów
IL260078B (en) Therapy used to treat Gaucher disease
IL238722A0 (en) New annals of indole for the treatment of cancer, viral infections, and lung disease
BR112013006857A2 (pt) composição farmacêutica, processo para preparar uma composição farmacêutica, uso de uma composição farmacêutica e método para o tratamento ou profilaxia de doenças virais
WO2015150362A3 (de) Chirale 2,5-disubstituierte cyclopentancarbonsäure-derivate und ihre verwendung
SMT201800560T1 (it) Derivati di 1,3-diidroimidazol-2-tione per uso nel trattamento di ipertensione arteriosa polmonare e lesione del polmone
CL2014001046A1 (es) Proceso de preparacion de compuestos derivados de acilguanidinas y aciltioureas, utiles para el tratamiento de enfermedades de los pulmones y de las vias respiratorias; y compuestos intermediarios utilizados en dicho proceso.
CL2014001823A1 (es) Procedimiento de preparacion estereoselectiva de un compuesto derivado de 9-hidroxi-5-oxo-1,4-diaza-espiro [5.5] undecano; compuestos intermediarios; uso en el tratamiento de enfermedades tumorales, enfermedades del pulmon y de las vias respiratorias.
ZA201402477B (en) Compounds for use in the treatment of alzheimer's disease
PT3044215T (pt) Processos para a preparação de medicamentos para o tratamento de doenças cardiovasculares e intermediários para utilização no mesmo
WO2015200349A3 (en) Elastase inhibitors